PEB - Pacific Edge Ltd

[twotic]

Hi Twotic and NewGuy,

There is no scale and we also don’t know the ratio of sales tests to user programme tests, but one can get a reasonable feel for the likely FY15 revenue results.

This is where I’ve got to;

There are arguments for there being a higher ratio of sales to user tests at FY15 than at HY15, and there are also arguments for there being a lower ratio of sales to user tests at FY15. Those influences will probably pretty much, more or less, cancel out I believe.

I’m quite comfortable with a base case estimate of $3.86M, but would like to be pleasantly surprised.

Edison’s estimate is $3.19M, so we may very well see an outperform on the day, all on track or better.

http://s300.photobucket.com/user/mcl...tml?sort=3&o=0

Attachment 7216

Cheers Mac - good post!

[twotic]

Disagree. The last time they showed this info they also overlaid the corresponding growth rates, from which the axis scale can be easily determined.

At the end of the day you still need to make assumptions to use the information contained in the graph in any meaningful way and it is completely unnecessary - that is all I am saying. On top of that it concerns me that PEB are presenting information in this way - it strikes me as extremely unprofessional.

You have an analytical background - would you ever put your name to a report with a figure as flawed as that one?

[skid]

Its possible it may have something to do with the fact that Parry Guilford is Chief Scientific Officer for PEB.
It also may have something to do with PEB having first dibs on anything developed in the Cancer Genetics Laboratory.
Drawing a long bow but if PEB can find it AND fix it - draw your own conclusions.


Sorry , others posted while under construction.

Do you have information to show that they have first dibs on anything developed in the cancer Genetics lab--Otago university has a number of business partners.

[MAC]

From the Prospectus.

Pacific Edge Biotechnology commenced trading in August 2001 and is based in large part on intellectual property acquired from the University of Otago pursuant to an Acquisition Agreement which is described below and in section 17 on page 49 of this Offer Document.

Pacific Edge Biotechnology has acquired rights in the following from the University of Otago pursuant to the Acquisition Agreement:

1. Two patent applications relating to multivariate data analysis and bio-informatics; an
2. All intellectual property related directly or indirectly to the knowledge of cancer, cancer biology, cancer genetics, genetic technology, bioinformatics and microarrays developed by the Cancer Genetics Laboratory and their collaborators or the Knowledge Engineering Laboratory and their collaborators.

I'm not sure which is more astonishing really, the comprehensiveness of all your good research and contributions after 10 years Hancocks, or the comprehensiveness of that agreement !

[hilskin]

http://www.otago.ac.nz/otagomagazine...ago080116.html

The company also benefits from a legacy agreement between the University of Otago and Pacific Edge. As part of the agreement at the inception of the company, the University received a 25 per cent share and committed to contribute future ongoing pieces of intellectual property for Pacific Edge to commercialise as a “pathway to market” company.

“Backing a new ‘start-up’ was a big commitment and, because of the agreement, we have maintained a very close relationship with the University. It’s a good example of how you can couple academic capability and resources from the University with a commercial enterprise and make a lasting legacy-type arrangement that benefits both parties,” Darling says.

[Leftfield]

Perhaps this will answer your question

Thanks to Twotic, Mac and Minerbarejet. Your info and help appreciated. Interesting times!!

[skid]

Thanks guys--I didnt know specifically how that works.
In the report they mentioned that PEB had put considerable money into the initial research for CX etc I assume so its easy to understand how they had exclusive rights to that material and intellectual property(at a price i assume)
But it was not clear about any of the new developments--Who funds them?
I also noticed there is an agricultural business involved.(not sure where they stand in the pecking order)

[Minerbarejet]

Thanks guys--I didnt know specifically how that works.
In the report they mentioned that PEB had put considerable money into the initial research for CX etc I assume so its easy to understand how they had exclusive rights to that material and intellectual property(at a price i assume)
But it was not clear about any of the new developments--Who funds them?
I also noticed there is an agricultural business involved.(not sure where they stand in the pecking order)

I think this is where it all ties in with the R &D grants and funding from Callaghan Institute at roughly 1.5 mil per annum for the next three years, Skid. Plus whatever else gets chucked at it. I guess in a roundabout way PEB could be considered Otago University's Commercial Arm for getting the results of their research into the public arena. Payback will be in the form of dividends eventually I suppose which will then get put back into the pot as well.
In addition I dont think Otago University would be terribly chuffed about PEB being taken over either if it comes to that. I suppose the cxbladder developments could be sold on their own but they would still be in the market with colorectal, melanoma, gastric, all of which seem to be coming over the development horizon and into a medical centre near you.
Plus anything else they develop in the meantime in other cancer related fields and in that laboratory.
Another thing is that every time they do a test anywhere it is added to the databank of knowledge gained which in turn further validates the science.

[skid]

http://www.otago.ac.nz/otagomagazine...ago080116.html

The company also benefits from a legacy agreement between the University of Otago and Pacific Edge. As part of the agreement at the inception of the company, the University received a 25 per cent share and committed to contribute future ongoing pieces of intellectual property for Pacific Edge to commercialise as a “pathway to market” company.

“Backing a new ‘start-up’ was a big commitment and, because of the agreement, we have maintained a very close relationship with the University. It’s a good example of how you can couple academic capability and resources from the University with a commercial enterprise and make a lasting legacy-type arrangement that benefits both parties,” Darling says.

So if Im getting this right Otago uni owns 25% of PEB-right?

[Xerof]

So if Im getting this right Otago uni owns 25% of PEB-right?

They currently hold 0.86%. Dilution, or sell-down in the very early years, I do not know. They held 5.8m shares in 2010, now they hold 2.648m. Look up the old A/R's if you want this information